Search
for
Sort by
Research 31–60 of 1000+
- Correction to: An evaluation of the federal adverse events reporting system data on adverse effects of 5‑alpha reductase inhibitors
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- A pharmacovigilance study of drug‐reduced male semen quality based on the Food and Drug Administration adverse event reporting system database
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- A Gender Hypothesis of sex disparities in adverse drug events
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Machine Learning–Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated with Minoxidil
- Machine Learning–Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated with Minoxidil
- Machine Learning--Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated With Minoxidil
- The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sun protection policies and behaviors among U.S. child care centers
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- Supplementary Material for: Finasteride and Suicide: A Postmarketing Case Series
- How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
- Sunscreen: Cosmetic or medical therapy?
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- Reporting on Adverse Clinical Events
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis